Auguste Deter was born 175 years ago on May 16, 1850. Though the story of her life is not widely known, it should be. Through ...

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the ...

The median age at symptom onset in the cohort was 55 years, ranging from 16 to 81 years. Data from patients’ initial ...

Foralumab is the only fully human anti-CD3 monoclonal antibody in clinical development for intranasal delivery. By modulating ...

Young-Onset Parkinson's Disease (YOPD) is on the rise in India. Genetic research is crucial for early diagnosis, offering ...

Symptoms can range from memory loss and difficulties with mental agility, judgement, and speed of thought to changes in mood, ...

The findings show that memory clinics can have “the infrastructure and expertise to safely administer and care for patients ...

Boston University was awarded $15 million to understand how to diagnose CTE when someone is alive. CTE is a brain disease ...

Almost one million people in the UK are thought to be living with dementia, but a doctor has shared some ways to lower your ...

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.

Providers say low reimbursements for respite services and eligibility rules are presenting challenges in the CMS GUIDE program.

A new clinical trial, delivered in Cardiff, will investigate the use of a one-time gene therapy to stop the disease ...